Interestingly, elevated HPX levels in the CSF after SAH were associated with a higher likelihood of delayed cerebral ischemia and poorer neurological outcomes, which differed from the effects of HPX in other diseases (74). The gene discussed is HPX; the disease is brain ischemia.